Guangzhou Yinming Biomedical Technology
PrivateLast Round
Private Equity
Jul 8, 2022
Est. Valuation
$616M
Total Funding Raised
$129.4M
Company Overview
Guangzhou Yinming Biomedical Technology is a biotechnology company that develops pharmaceutical drugs, including ophthalmic medications, recombinant botulinum toxins, immuno-oncology therapies, and veterinary immune drugs.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Guangzhou Yinming Biomedical Technology Comparables
Compare Guangzhou Yinming Biomedical Technology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Fosun Pharma | 75% | |
| Arctic Vision | 46% | |
| VivaVision Biotech | 37% |
Guangzhou Yinming Biomedical Technology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | Jul 8, 2022 | ||||
| Series A Extension | Sep 13, 2021 | ||||
| Series A | Mar 17, 2021 |
Guangzhou Yinming Biomedical Technology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fosun RZ Capital | Series A Extension |
| JCP Capital | Series A |
| Oceanpine Capital | Series A Extension |
| Huajin Capital | Series A, Series A Extension |
| Lightspeed China Partners | Series A |
| Tiger Jade Capital | Series A Extension |
| Flower City Ventures | Series A, Series A Extension |
Guangzhou Yinming Biomedical Technology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Guangzhou Yinming Biomedical Technology's valuation, stock price, and market status.
Is Guangzhou Yinming Biomedical Technology a public or private company?
Guangzhou Yinming Biomedical Technology is a private company.
What is the current stock price of Guangzhou Yinming Biomedical Technology?
Guangzhou Yinming Biomedical Technology is a private company with no public stock price. No recent secondary market data is available.
How much is Guangzhou Yinming Biomedical Technology worth (valuation)?
Valuation information for Guangzhou Yinming Biomedical Technology is not publicly available.
Can I buy Guangzhou Yinming Biomedical Technology stock?
Guangzhou Yinming Biomedical Technology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Guangzhou Yinming Biomedical Technology's last funding round?
Guangzhou Yinming Biomedical Technology's most recent funding round was Series A Extension on September 13, 2021.
Who are the main investors in Guangzhou Yinming Biomedical Technology?
Key investors in Guangzhou Yinming Biomedical Technology include Gaorong Capital.
Will Guangzhou Yinming Biomedical Technology IPO soon?
No public IPO plans have been announced for Guangzhou Yinming Biomedical Technology.
How can I track Guangzhou Yinming Biomedical Technology secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Guangzhou Yinming Biomedical Technology's secondary market activity and sign up for updates.